Clinical Trials in New York

Showing 14261-14280 of 22,668 trials

Effect of CES on Parasympathetic Tone

NCT02163967

The hypothesis is that CES stimulation will dose dependently increase parasympathetic tone. Healthy subjects will have three 20 minute sessions of CES stimulation, at three different intensities of stimulation, with each session occurring on a separate day. Effect on parasympathetic tone will determined by measuring high frequency heart rate variability before, during and after the stimulation. The Fisher Wallace Stimulator (FW100) which delivers a low dose alternating current a varying frequencies will be used for the stimulation.

Autonomic Nervous System Imbalance

Weill Medical College of Cornell University21 participantsStarted Jan 2013

New York, New York, United States

TERMINATEDPhase 3< 1 mile

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

NCT01390220

The purpose of this study is to examine the safety and effectiveness of USL261 for the outpatient treatment of seizure clusters.

Epilepsy

UCB Biopharma S.P.R.L.292 participantsStarted Jun 2011

Phoenix, Arizona, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +87 more locations

Effect of CES on Parasympathetic Tone

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Find Trials by Condition in New York

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo

Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Evaluation of Discomfort Associated With Scleral Depression During Retina Examinations

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Trial of IMO-8400 in Adult Patients With Dermatomyositis

ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation

Post Market Clinical Follow Up Study for ReliaTack™ Articulating Reloadable Fixation Device With Deep Purchase Tacks

Collagenase in the Treatment of Adhesive Capsulitis (Frozen Shoulder)

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency

Building an Optimal Hand Hygiene Bundle

A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)

e-NOBORI Observational Registry of Nobori DES